Species differences in toxicokinetic parameters of glycidol after a single dose of glycidol or glycidol linoleate in rats and monkeys.

Glycidol fatty acid esters (GEs) have been identified as contaminants in refined edible oils. Although the possible release of glycidol (G) from GEs is a concern, little is known about the conversion of GEs to G in the human body. This study addressed the toxicokinetics of glycidol linoleate (GL) and G in male Crl:CD(SD) rats and cynomolgus monkeys. Equimolar amounts of GL (341 mg/kg) or G (75 mg/kg) were administered by gavage to each animal. G was found in both species after the G and GL administration, while plasma GL concentrations were below the lower limit of quantification (5 ng/ml) in both species. In rats, the administration of GL or G produced similar concentration-time profiles for G. In monkeys, the C(max) and AUC values after GL administration were significantly lower than those after G administration. The oral bioavailability of G in monkeys (34.3%) was remarkably lower than that in rats (68.8%) at 75 mg/kg G administration. In addition, plasma G concentrations after oral administration at three lower doses of GL or G were measured in both species. In monkeys, G was detected only at the highest dose of G. In contrast, the rats exhibited similar plasma G concentration-time profiles after GL or G administration with significantly higher G levels than those in monkeys. In conclusion, these results indicate that there are remarkable species differences in the toxicokinetics of GEs and G between rodents and primates, findings that should be considered when assessing the human risk of GEs.

[1]  N. Nishiyama,et al.  Measurement of glycidol hemoglobin adducts in humans who ingest edible oil containing small amounts of glycidol fatty acid esters. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  G. Eisenbrand,et al.  Identification of gaps in knowledge concerning toxicology of 3‐MCPD and glycidol esters , 2011 .

[3]  Shun Nakamura,et al.  A new analytical method for the quantification of glycidol fatty acid esters in edible oils. , 2010, Journal of oleo science.

[4]  C. Kirman,et al.  Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[5]  R. J. Nolan,et al.  In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human , 2005, Archives of Toxicology.

[6]  W. P. Watson,et al.  Metabolic inactivation of 2-oxiranylmethyl 2-ethyl-2,5-dimethylhexanoate (C10GE) in skin, lung and liver of human, rat and mouse. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  J. A. Bond,et al.  The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. , 1996, Toxicology and applied pharmacology.

[8]  J. A. Bond,et al.  Glutathione conjugation of 1,2:3,4- diepoxybutane in human liver and rat and mouse liver and lung in vitro. , 1996, Toxicology and applied pharmacology.

[9]  G. L. Kedderis,et al.  Conjugation of acrylonitrile and 2-cyanoethylene oxide with hepatic glutathione. , 1995, Toxicology and applied pharmacology.

[10]  T. Kararli Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[11]  A. Nomeir,et al.  Comparative disposition of 2,3-epoxy-1-propanol (glycidol) in rats following oral and intravenous administration. , 1995, Journal of toxicology and environmental health.

[12]  G. L. Kedderis,et al.  Species differences in the hydrolysis of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile. , 1993, Carcinogenesis.

[13]  J. A. Bond,et al.  Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. , 1992, Carcinogenesis.

[14]  R. Irwin NTP Toxicology and Carcinogenesis Studies of Glycidol (CAS No. 556-52-5) In F344/N Rats and B6C3F1 Mice (Gavage Studies). , 1990, National Toxicology Program technical report series.

[15]  M. Hamosh,et al.  Lingual and gastric lipases: species differences in the origin of prepancreatic digestive lipases and in the localization of gastric lipase. , 1988, Biochimica et biophysica acta.

[16]  J. M. Patel,et al.  The biotransformation of allyl alcohol and acrolein in rat liver and lung preparations. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[17]  Jones Ar The Metabolism of 3-Chloro-, 3-Bromo- and 3-Iodopropan-1,2-diol in Rats and Mice , 1975 .

[18]  A. Jones The metabolism of 3-chloro,- 3-bromo- and 3-iodoprpan-1,2-diol in rats and mice. , 1975, Xenobiotica; the fate of foreign compounds in biological systems.